{"id":"https://openalex.org/W4361947633","doi":"https://doi.org/10.1158/1535-7163.c.6532245","title":"Data from Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy","display_name":"Data from Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor Efficacy","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361947633","doi":"https://doi.org/10.1158/1535-7163.c.6532245"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6532245","doi":"https://doi.org/10.1158/1535-7163.c.6532245","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6532245","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.c.6532245","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051084648","display_name":"Clara Albanese","orcid":"https://orcid.org/0009-0009-9302-6245","observed_orcids":["https://orcid.org/0009-0009-9302-6245"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clara Albanese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049504158","display_name":"Rachele Alzani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachele Alzani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007214576","display_name":"Nadia Amboldi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadia Amboldi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026821481","display_name":"Nilla Roberta Avanzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nilla Avanzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018214424","display_name":"Dario Ballinari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dario Ballinari","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031466676","display_name":"Maria Gabriella Brasca","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Gabriella Brasca","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002876711","display_name":"Claudio Festuccia","orcid":"https://orcid.org/0000-0002-3463-6475","observed_orcids":["https://orcid.org/0000-0002-3463-6475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudio Festuccia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085619076","display_name":"Francesco Fiorentini","orcid":"https://orcid.org/0009-0002-0743-6168","observed_orcids":["https://orcid.org/0009-0002-0743-6168"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Fiorentini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Giuseppe Locatelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppe Locatelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042529900","display_name":"Wilma Pastori","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wilma Pastori","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072610596","display_name":"Veronica Patton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veronica Patton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080881030","display_name":"Fulvia Roletto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fulvia Roletto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021457170","display_name":"Francesco Colotta","orcid":"https://orcid.org/0000-0001-8601-2309","observed_orcids":["https://orcid.org/0000-0001-8601-2309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Colotta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904834","display_name":"Arturo P. Galvani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arturo Galvani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008691829","display_name":"Antonella Isacchi","orcid":"https://orcid.org/0000-0001-9853-9001","observed_orcids":["https://orcid.org/0000-0001-9853-9001"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonella Isacchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028716907","display_name":"Jurgen Moll","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jurgen Moll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083934929","display_name":"Enrico A. Pesenti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Enrico Pesenti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023227792","display_name":"Ciro Mercurio","orcid":"https://orcid.org/0000-0001-6240-4607","observed_orcids":["https://orcid.org/0000-0001-6240-4607"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ciro Mercurio","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044377393","display_name":"Marina Ciomei","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marina Ciomei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.6571999788284302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.6571999788284302,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.23720000684261322,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.03840000182390213,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.6539999842643738},{"id":"https://openalex.org/keywords/trk-inhibitors","display_name":"TRK inhibitors","score":0.8379999995231628},{"id":"https://openalex.org/keywords/trk-receptors","display_name":"Trk receptors","score":0.8610000014305115},{"id":"https://openalex.org/keywords/cyclin-dependent-kinases","display_name":"cyclin-dependent kinases","score":0.859000027179718},{"id":"https://openalex.org/keywords/dual-kinase-inhibitors","display_name":"dual kinase inhibitors","score":0.7310000061988831},{"id":"https://openalex.org/keywords/rb-phosphorylation","display_name":"retinoblastoma protein phosphorylation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/g1-cell-cycle-arrest","display_name":"G1 cell cycle arrest","score":0.9670000076293945},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.8029999732971191},{"id":"https://openalex.org/keywords/carcinogen-induced-tumors","display_name":"carcinogen-induced tumors","score":0.8790000081062317},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.6370000243186951},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.8259999752044678}],"concepts":[{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.821041464805603},{"id":"https://openalex.org/C134139212","wikidata":"https://www.wikidata.org/wiki/Q24719927","display_name":"Trk receptor","level":4,"score":0.6661479473114014},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5885023474693298},{"id":"https://openalex.org/C2778298596","wikidata":"https://www.wikidata.org/wiki/Q17143494","display_name":"CDK inhibitor","level":5,"score":0.5476549863815308},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.48977231979370117},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4874143898487091},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4679352939128876},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.44430291652679443},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.3675619959831238},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3429112136363983},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3216210603713989},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2673545777797699},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.26434335112571716},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17898941040039062},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.11154311895370483}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6532245","doi":"https://doi.org/10.1158/1535-7163.c.6532245","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6532245","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6532245","doi":"https://doi.org/10.1158/1535-7163.c.6532245","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6532245","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2130915160","https://openalex.org/W7097431620","https://openalex.org/W2327532083","https://openalex.org/W1970888488","https://openalex.org/W2270175471","https://openalex.org/W1987923857","https://openalex.org/W2733835459","https://openalex.org/W1985968189","https://openalex.org/W2120350411","https://openalex.org/W2045875750"],"abstract_inverted_index":{"Abstract":[0],"Altered":[1],"expression":[2],"and":[3,9,53,69,99,109,122,144,205],"activity":[4,139],"of":[5,21,44,67,80,84,106,111,120,174],"cyclin-dependent":[6],"kinase":[7,12],"(CDK)":[8],"tropomyosin":[10],"receptor":[11],"(TRK)":[13],"families":[14],"are":[15],"observed":[16],"in":[17,97,125,140,150,158,160,168,179,183],"a":[18,63,81,203],"wide":[19,82],"variety":[20],"tumors.":[22],"In":[23],"those":[24,165],"malignancies":[25],"with":[26,88,155],"aberrant":[27],"CDK":[28],"activation,":[29],"the":[30,59,161,193,199],"retinoblastoma":[31],"protein":[32],"(pRb)":[33],"pathway":[34],"is":[35,46],"deregulated,":[36],"leading":[37],"to":[38,49],"uncontrolled":[39],"cell":[40,51,78,86,94,171],"proliferation.":[41,172],"Constitutive":[42],"activation":[43],"TRKs":[45],"instead":[47],"linked":[48],"cancer":[50,170,210],"survival":[52],"dissemination.":[54],"Here,":[55],"we":[56],"show":[57,93,191],"that":[58,192],"novel":[60,204],"small-molecule":[61],"PHA-848125,":[62],"potent":[64],"dual":[65,194],"inhibitor":[66,196],"CDKs":[68],"TRKs,":[70],"possesses":[71],"significant":[72,137],"antitumor":[73,138],"activity.":[74],"The":[75,115],"compound":[76,116],"inhibits":[77,118],"proliferation":[79],"panel":[83],"tumoral":[85],"lines":[87],"submicromolar":[89],"IC50.":[90],"PHA-848125\u2013treated":[91],"cells":[92],"cycle":[95],"arrest":[96],"G1":[98],"reduced":[100],"DNA":[101],"synthesis,":[102],"accompanied":[103],"by":[104],"inhibition":[105],"pRb":[107],"phosphorylation":[108,119],"modulation":[110],"other":[112],"CDK-dependent":[113],"markers.":[114],"additionally":[117],"TRKA":[121],"its":[123],"substrates":[124],"cells,":[126],"which":[127],"functionally":[128],"express":[129],"this":[130],"receptor.":[131],"Following":[132],"oral":[133],"administration,":[134],"PHA-848125":[135,197],"has":[136,198],"various":[141],"human":[142],"xenografts":[143],"carcinogen-induced":[145],"tumors":[146],"as":[147,149,164,181],"well":[148],"disseminated":[151],"primary":[152],"leukemia":[153],"models,":[154],"plasma":[156],"concentrations":[157],"rodents":[159],"same":[162],"range":[163],"found":[166],"active":[167],"inhibiting":[169],"Mechanism":[173],"action":[175],"was":[176],"also":[177],"confirmed":[178],"vivo":[180],"assessed":[182],"tumor":[184],"biopsies":[185],"from":[186],"treated":[187],"mice.":[188],"These":[189],"results":[190],"CDK-TRK":[195],"potential":[200],"for":[201,209],"being":[202],"efficacious":[206],"targeted":[207],"drug":[208],"treatment.":[211],"Mol":[212],"Cancer":[213],"Ther;":[214],"9(8);":[215],"2243\u201354.":[216],"\u00a92010":[217],"AACR.":[218]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-05T00:00:00"}